/Edwards%20Lifesciences%20Corp%20logo%20on%20phone-%20by%20IgorGolovniov%20via%20Shutterstock.jpg)
Irvine, California-headquartered Edwards Lifesciences Corporation (EW), with a market cap of $40.5 billion, is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring.
Companies valued at $10 billion or more are generally considered "large-cap" stocks and Edwards Lifesciences fits this criterion perfectly, signifying its substantial size, stability, and influence in the medical devices industry. The company is a global leader in heart valve systems, known for its innovation and strong R&D investment, enhancing its market position and reputation.